Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3940890

ACORAMIDIS
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
Cc1n[nH]c(C)c1CCCOc1cc(C(=O)O)ccc1F

Basic Information

ChEMBL ID CHEMBL3940890
Name ACORAMIDIS
Phase Approved
Structure Type MOL
InChI Key WBFUHHBPNXWNCC-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Acoramidis AG-10 AG10
3
Targets
7
Activities
2
Assay Types
0
PK Parameters
9
Publications
3
Known Names
3
Indications
1
Mechanisms

Molecular Properties

292.3
MW (Da)
2.88
ALogP
3
HBA
2
HBD
75.2
PSA (Ų)
0.80
QED
0
Ro5 Violations
6
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2024
Availability Prescription
Chirality Achiral

Routes of Administration

Oral
USAN Stem -amidis
USAN Year 2020

Extended Properties

Molecular Formula C15H17FN2O3
MW 292.31
Aromatic Rings 2
Heavy Atoms 21
NP-Likeness -1.34

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Transthyretin stabiliser STABILISER Transthyretin

Indications

Amyloid Neuropathies, Familial Cardiovascular Diseases Amyloidosis

ATC Classification

C01EB25
acoramidis
Level 1: CARDIOVASCULAR SYSTEM
Level 2: CARDIAC THERAPY

Activity Summary

Kd 5 meas. best 8.32
IC50 2 meas. best 6.8

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Transthyretin
CHEMBL3194
Kd 8.32 7.82 4.8 4
Transthyretin
CHEMBL3194
IC50 6.8 6.8 160.0 1
Unchecked
CHEMBL612545
IC50 6.29 6.29 512.0 1
Albumin
CHEMBL3253
Kd 5.1 5.1 8000.0 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

Data from ChEMBL 36 via Core Engine